By annette
How does cancer care in Serbia compare in a European comparison? This dashboard-style report provides a visual and quantitative description of selected performance indicators in all areas of cancer care. It also provides evidence-based recommendations to improve cancer care. Overall, it shows that clear governance is lacking in the absence of an active national cancer …
By annette
As the Europe’s Beating Cancer Plan is entering its final years, the European Parliamentary Research Service (EPRS) published a comprehensive evaluation of its implementation in 2021-2024. IHE’s Thomas Hofmarcher served as the single external peer reviewer for the report. Download the report For more information please contact Thomas Hofmarcher
By annette
Visual impairment is a growing public health challenge in ageing societies. Many older adults live with undetected vision problems that affect daily functioning, safety, and independence. A new report from IHE – The Swedish Institute for Health Economics investigates the clinical, economic, and quality-of-life consequences of systematic vision screening among adults aged 75 and older …
By annette
Thomas Hofmarcher at the IHE has presented results on cancer and cancer care on several occasions during November, and on December 4, Thomas participates in European Cancer Forum in Brussels. the 7th European Cancer Forum (ECF) The 7th edition of the European Cancer Forum in Brussels focused the theme “Innovation, Security, and Sustainability – Shaping the …
By annette
New diagnostic methods now make it possible to tailor targeted treatments depending on the genomic profile expressed by the tumor in people with cancer. In lung cancer, there are over 10 different targeted treatments. Work is currently underway to identify people with other cancers who may benefit from targeted therapies. In this analysis, we estimate …
By annette
Cancer Dashboard for Denmark – Lung cancer How does lung cancer care in Denmark compare to Sweden and Norway? And how big are the regional differences within Denmark? This dashboard-style report provides a visual and quantitative description of selected performance indicators in all areas of lung cancer care. The analysis is based on data from …
By annette
Last week, joint work by DiaUnion, Sanofi, and IHE was presented at the ISPAD 2025 Conference in Montreal, Canada. The study focused on the development of a decision-analytic model to evaluate the cost-effectiveness of screening for Type 1 Diabetes, Celiac Disease, and Autoimmune Thyroid Disease in children. The model explores the synergistic impact of combined …
By annette
The Value of Investing in Healthcare was the topic of a presentation by Thomas Hofmarcher at a conference organized by the American Chamber of Commerce in Bosnia and Herzegovina. Thomas elaborated on questions such as What is value in healthcare?, How much should and can we invest in healthcare? What’s the role of innovation?, and …
By annette
We are looking for a colleague with 3–5 Years’ experience in health economic evaluations, Market Access and HTA. Read more
By annette
Screening programs play a crucial role in identifying diseases before symptoms appear, offering the potential to improve health outcomes, reduce complications, and optimize the use of healthcare resources. Recent research advances have opened up new possibilities to screen for type 1 diabetes (T1D) and potentially delay disease onset among those at risk. However, before any …